Sandra Karitzky

512 total citations
4 papers, 18 citations indexed

About

Sandra Karitzky is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Sandra Karitzky has authored 4 papers receiving a total of 18 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Public Health, Environmental and Occupational Health and 1 paper in Molecular Biology. Recurrent topics in Sandra Karitzky's work include CAR-T cell therapy research (4 papers), Acute Lymphoblastic Leukemia research (2 papers) and Chronic Lymphocytic Leukemia Research (1 paper). Sandra Karitzky is often cited by papers focused on CAR-T cell therapy research (4 papers), Acute Lymphoblastic Leukemia research (2 papers) and Chronic Lymphocytic Leukemia Research (1 paper). Sandra Karitzky collaborates with scholars based in Germany. Sandra Karitzky's co-authors include Franziska Blaeschke, Mario Assenmacher, Toni Cathomen, Dominik Lock, Claudia Rössig, Thomas Schaser, Tobias Feuchtinger, Andrew Kaiser, Silke Holtkamp and Paul G. Schlegel and has published in prestigious journals such as Blood and Molecular Therapy — Methods & Clinical Development.

In The Last Decade

Sandra Karitzky

4 papers receiving 18 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Karitzky Germany 3 14 8 6 5 4 4 18
Soraya Kharboutli Germany 2 15 1.1× 3 0.4× 5 0.8× 9 1.8× 2 0.5× 4 18
Keagan S. Casey United States 3 23 1.6× 11 1.4× 4 0.7× 7 1.4× 2 0.5× 4 24
Jennemiek van Arkel Netherlands 4 13 0.9× 2 0.3× 8 1.3× 4 0.8× 3 0.8× 5 20
Ryan Moslin United States 2 7 0.5× 6 0.8× 7 1.2× 5 1.0× 4 1.0× 3 23
Jennifer Ploski United Kingdom 2 9 0.6× 5 0.6× 5 0.8× 7 1.4× 5 27
Svetlana Balandraud France 2 20 1.4× 6 0.8× 13 2.2× 4 0.8× 4 23
Kristin Kreider United States 3 23 1.6× 5 0.6× 5 0.8× 9 1.8× 4 25
Orla Stewart United Kingdom 4 31 2.2× 9 1.1× 8 1.3× 2 0.4× 2 0.5× 6 39
Lisa Frölich Germany 2 27 1.9× 7 0.9× 6 1.0× 10 2.0× 5 1.3× 6 31
Joanne Shea United States 2 27 1.9× 6 0.8× 10 1.7× 8 1.6× 1 0.3× 2 29

Countries citing papers authored by Sandra Karitzky

Since Specialization
Citations

This map shows the geographic impact of Sandra Karitzky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Karitzky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Karitzky more than expected).

Fields of papers citing papers by Sandra Karitzky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Karitzky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Karitzky. The network helps show where Sandra Karitzky may publish in the future.

Co-authorship network of co-authors of Sandra Karitzky

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Karitzky. A scholar is included among the top collaborators of Sandra Karitzky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Karitzky. Sandra Karitzky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Kutsch, Nadine, Philipp Gödel, Udo Holtick, et al.. (2022). A Phase I Dose Finding Trial of MB-CART20.1 in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma. Blood. 140(Supplement 1). 12980–12981. 2 indexed citations
2.
Lock, Dominik, Franziska Blaeschke, Sandra Karitzky, et al.. (2021). Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cells. Molecular Therapy — Methods & Clinical Development. 21. 42–53. 10 indexed citations
3.
Mackensen, Andréas, Linda Hanssens, Matthias Stelljes, et al.. (2021). A Phase I Open Label Dose Escalation Study of MB-CART19.1 in Relapsed and Refractory CD19+ B Cell Malignancies, Interim Preliminary Results in Pediatric ALL, Adult ALL Including CLL Cohorts. Blood. 138(Supplement 1). 3836–3836. 2 indexed citations
4.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Soraya Kharboutli Breakdown of academic impact, for papers by Keagan S. Casey Breakdown of academic impact, for papers by Jennemiek van Arkel Breakdown of academic impact, for papers by Ryan Moslin Breakdown of academic impact, for papers by Jennifer Ploski Breakdown of academic impact, for papers by Svetlana Balandraud Breakdown of academic impact, for papers by Kristin Kreider Breakdown of academic impact, for papers by Orla Stewart Breakdown of academic impact, for papers by Lisa Frölich Breakdown of academic impact, for papers by Joanne Shea
Rankless by CCL
2026